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Abstract
Background: The three-parent assisted reproductive technique may increase oocyte
competence.
Objective: In this case-control study, the suitability of germinal vesicle transfer
(GVT), synchronous ooplasmic transfer (sOT), asynchronous ooplasmic transfer using
cryopreservedMII oocyte (caOT), and asynchronous ooplasmic transfer usingwasteMII
oocyte (waOT) for maturation of the human-aged non-surrounded nucleolus germinal
vesicle-stage (NSN-GV) oocyte were investigated.
Materials and Methods: NSN-GV oocytes were subjected to four methods: group A
(GVT), B (sOT), C (caOT) D (waOT), and E (Control). The fusion rates, MI, MII, ICSI
observations and cleavage at 2-cell, 4-cell, and 8-cell stages were compared in the
groups.
Results: In GVT, none of the oocytes fused. In sOT, all oocytes fused, 20 achieved
the MI, 14 progressed to MII, 8 fertilized, 6 cleaved and 5, 4, and 3 achieved the 2-
cells, 4-cells and 8-cells, respectively. In caOT, all oocytes fused and achieved the MI,
8 progressed to MII and fertilized, 6 cleaved and 6, 5, and 5 achieved the 2-cells, 4-
cells, and 8-cells respectively. In waOT, all oocytes fused, 5 and 3 progressed to MI and
MII, respectively, but only one fertilized, cleaved and reached a 4-cells stage. In group
E, 6 and 2 oocytes progressed to MI and MII, respectively, and only one fertilized but
arrested at the zygote stage. caOT had the highest survival rate when compared to
sOT (p = 0.04), waOT (p = 0.002), and control (p = 0.001).
Conclusion: The caOT method was beneficial over sOT, waOT, and GVT in
supplementing the developmental capacity of human-aged NSN-GV oocytes.
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Nuclear transfer techniques, Oocytes, Oocyte donation.
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1. Introduction
In vitro maturation (IVM) of human oocytes
has contributed to several births withstanding
variations in patient disorders (such as premature
ovarian failure and polycystic ovary syndrome),
oocyte types (such as germinal vesicle [GV] and
MI), and culture media. However, IVM success rates
in terms of live birth remain low as compared to in
vivo maturation (1-3). The insufficiency of suitable
culture media and deficiencies in the oocytes
due to variations in their developmental capacity
might explain the meager effectiveness of IVM
in assisted reproduction (3, 4). Moreover, both
the in vivo and in vitro embryonic developmental
success depends on the initial oocyte status and,
especially, the quality of the GV oocyte (5).
The GV oocyte pool comprises two major types,
namely, the “not-surrounded nucleolus” (NSN)
and the “surrounded nucleolus” (SN) (6). The SN
oocytes account for nearly 70-80% of GV oocyte
pool and are likely the ones that naturally ovulate
and endure the complete embryonic development
after both in vivo and IVM and fertilization (6). The
NSN oocytes account for the remaining 20-30%,
which have stopped growing at the 2- or 4-cell
stage after fertilization, as observed in IVM and in
vitro fertilization studies (7-9).
The oocyte quality is a necessary factor to drive
embryonic development via renewal, maturation,
fertilization, and implantation (5). Oocyte quality
includes numerous functional events like cellular
organizations, metabolism, protein translation,
DNA transcription, and several other factors
that need to be considered (5). Nevertheless,
women at advanced reproductive age often have
a poor ovarian reserve. As a result, the oocyte
cohort obtained after ovarian stimulation is usually
limited and of poor quality overall, irrespective of
the regimen used for ovarian stimulation (10, 11).
The development of methods for the maturation
of NSN-GV oocytes is advantageous as they
might increase the number of developmentally
competent oocytes for in vitro fertilization.
Ten methods have been used to increase the
ooplasmic maturation, including nuclear transfer,
cytoplasmic (ooplasmic) transfer, allotropic
rescue, import of normal RNAs to mitochondria,
mitochondrial injection, injection of mtDNA, usage
of mitochondrial transcription factor A (TFAM),
usage of the inner mitochondrial membrane
potential (MMP) and free Ca2+ levels, dietary
supplementation with cofactors and vitamins,
and gonadotropin injections (12). The nuclear
transfer may be performed in three oocyte
developmental stages containing the GV, MII,
and pronuclear (PN) (12). The two types of OT
techniques are synchronous ooplasmic transfer
(sOT) and asynchronous ooplasmic transfer (aOT)
(4). In this project, germinal vesicle transfer (GVT),
sOT, aOT using cryopreserved MII oocytes (caOT),
and aOT using waste MII oocytes (waOT) have
been used to improve the human aged NSN-GV
oocytes’ quality.
Our group has been focused on finding ways
to improve the growth, viability, and overall quality
of immature human aged NSN-oocytes. Our aim
has been to find remedies to make such oocytes
fit for use in ART thereby allowing the formation
of a viable and healthy embryo. In this study, we
compare for the first time the effectiveness of four
three-parent techniques for the maturation of aged
GV oocytes.
2. Materials and Methods
2.1. Source of human oocytes
In this case-control study, the oocytes were
provided through female partners of infertile
couples who underwent ART treatment at
the Avicenna infertility clinic affiliated with
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Avicenna Research Institute, Tehran, Iran, from
September 2016 to September 2017. None
of the volunteers had any history of chronic
diseases (diabetes, cancer, etc.) or any genital
inflammation, chromosomal aberrations, and
endocrine abnormality.
The following four types of donated oocytes
were utilized in this study from women undergoing
intracytoplasmic sperm injection (ICSI) after
standardized controlled ovarian stimulation: (1)
discarded-aged NSN-GV oocytes obtained from
participants aged 38 yr and older, (2) discarded
young SN-GV oocyte from participants aged 34
yr and younger, (3) cryopreserved good-quality
young MII oocytes from participants aged 34 yr
and younger, and (4) waste low-quality young MII
oocyte from participants aged 34 yr and younger.
2.2. Controlled ovarian stimulation,
oocyte handling
The cumulus cell-oocyte complexes (COCs)
were retrieved from women who underwent
controlled ovarian hyperstimulation with
recombinant human FSH (r-hFSH, Merck Fertility,
Germany) after pituitary suppression with
gonadotropin-releasing hormone (GnRH, Merck
Fertility, Germany) agonist. The r-hFSH dose was
200 IU/day for the first four days and was adjusted
on the fifth day accordingly, if needed, based on
the volume and number of ovarian follicles and
the serum levels of estradiol (E2). When at least
three follicles became 18 mm, the COCs were
retrieved transvaginally 36 hr after hCG trigger
(5,000 or 10,000 IU) (Merck Fertility, Germany). The
cumulus-corona cells (CCs) of COCs were removed
chemically by a short-term exposure (the 40 sec)
of them to medium (G-MOPSTMPLUS, Vitrolife,
Sweden) with 80 IU/mL hyaluronidase (Sigma,
USA) and repetitious pipetting. Subsequently,
all oocytes were considered for development




The cryopreservation protocol involved an
oocyte vitrification method. Only MII oocytes
were vitrified at about 20°C based on a protocol
(15). The oocytes were placed in the vitrification
solution (VS) for 90 sec. According to this, oocytes
were equilibrated for 1 min in 20 μl medium
(G-MOPSTMPLUS, Vitrolife, Sweden). Following
oocytes were placed in 20 μl equilibration solution
(ES) (Vitrolife, Sweden) with 7.5% (v/v) dimethyl
sulphoxide (DMSO) (Sigma, USA) and 7.5% (v/v)
ethylene glycol (EG) (Sigma, USA) for 2 min, and
after that into another 20 μl ES for 2 min. The
oocytes were exposed to the 20 μl ES for 5 min
and then into three 20 μl drops of VS composed
of 0.5 M sucrose (Sigma, USA), 15% (v/v) DMSO,
and 15% (v/v) EG and were then loaded in plastic
straws (Cryotpo, Kitazato, Japan) and put into
cooled protective straws in liquid nitrogen for
cryopreservation. Two or three oocytes were
vitrified on one straw and the straws were moved
into liquid nitrogen tanks and kept until thawing.
To thaw, the straws were taken from liquid
nitrogen tanks and placed in 1-ml 1.0 M sucrose
(37°C) for 1 min. After that, oocytes were moved to
1-ml 0.5 M sucrose for 3 min and to 1 ml medium
(G-MOPSTMPLUS, Vitrolife, Sweden) for 10 min at
20°C. Finally, oocytes were washed and cultured
in the medium (G-MOPSTMPLUS, Vitrolife, Sweden)
with 10% serum protein substitute (SPS, IVFonline
CT, USA) for 1 hr before manipulation. After 1
hr, the oocytes were assessed. The oocytes with
normal size, intact zona pellucida clear perivitelline
space, and well plasmamembranewere defined as
“survived.”
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The young fresh SN-GV oocytes, cryo-thawed
young MII oocytes, and waste young fresh
MII oocytes were used as an auxiliary cell for
providing ooplasmic substrates for recipient fresh
NSN-GV-aged oocytes. Four experimental groups
were established according to the category
of oocyte providing this substrate to NSN-
GV oocytes as follows: Group A (GVT, n = 10),
Group B (sOT, n = 26), Group C (asynchronous
ooplasmic transfer using caOT, n = 12), Group
D (asynchronous ooplasmic transfer using
waOT, n = 12), and Group E (Control, aged
NSN-GV oocytes from participants aged 38
and older, n = 12) (Figure 1 showed the study
design).
The developmental stage and status of oocyte
were confirmed using the inverted microscope
(Diaphot, Nikon Corporation, Tokyo, Japan)
at 200× magnification. Oocyte manipulation,
GVT, sOT, caOT, and waOT were started
within 5 hr after oocyte denudation. A total
of 72 oocytes have been investigated in this
study.
2.4.2. Germinal vesicle transfer (GVT)
In group A, naked NSN-GV aged-oocytes were
incubated in medium (G-MOPSTMPLUS, Vitrolife,
Sweden) with 7.5 µg/ml cytochalasin B (CB, Sigma,
USA), 50 µg/ml 3-isobutyl-1-methylxanthine (IBMX,
Sigma, USA) for 1 hr at 37°C and 6%CO2 (16). Precise
localization of nuclear material was performed by
moving oocytes in the manipulating medium (G-
MOPSTMPLUS, Vitrolife, Sweden) containing 12%
PVA, 50 µg/ml IBMX, and 7.5 g/ml CB. The removal
of nucleus material was carried out “directly” with a
little surrounding ooplasm with the aid of a tapered
manipulating glass pipette (ID: 25 µm, QG: 45°
and θA: 35°) (Dain bioassay Co., Iran). The pipette
was inserted through a slit made in the overlying
zona pellucida using the XYCloneTM laser system
(Hamilton Thorne Biosciences, Beverly, MA, USA)
and lanced the zona pellucida directly covering
the GV (16). The pipette was withdrawn and the
pressure inside the holding pipette (OD: 100-150
µm, ID: 30-35 and θA: 30°) was increased gently to
eject the GV via the opening. The GV was injected
into an enucleated young oocyte subzonally (16).
Before the removal of GV, to reduce cohesion of the
membranes within the pipette, the pipettes were
rinsed in polyvinyl pyrrolidone 10% (PVP, Sigma,
USA). Following two mineral oil droplets were used
to control the fluid flow during the manipulation
(17). Subsequently, the reconstructed oocytes (ROs)
were rinsed three times and incubated in medium
(G-IVFTM -Vitrolife) at 37°C for at least 30 min until
electrofusion (16, 18). Membrane fusion between
oocyte and GV was achieved in a microfusion
chamber containing a solution of 0.3 M mannitol
(Sigma, USA), 0.1 mM calcium chloride (Sigma,
USA), 0.05 mg/mL human serum albumin (Sigma,
USA), and 0.1 mM magnesium sulfate (Sigma, USA)
at 20°C. After manual alignment, a single direct
current (DC) pulse (70 V/cm DC for 20 µs) was used
as a fusion pulse by the use of an ElectroCell Fusion
instrument (BTX 2001, BTX, USA) (16). The GVT
manipulation of agedNSN-GV oocytes is illustrated
in Figure 2. Finally, the oocytes were washed and
cultured (G-MOPSTMPLUS, Vitrolife, Sweden) with
10% serum protein substitute (SPS, IVF online CT,
USA) before ICSI.
2.4.3. Ooplasmic transfer (OT)
Figure 3 showed aged NSN-GV oocytes treated
with three methods of OT including sOT, caOT,
and waOT. As shown in Figure 3, in synchronous
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transfer (Group B), the ooplasm of the young
SN-GV replaced that of the aged NSN-GV, while
in asynchronous transfer (Groups C and D),
the replacement of ooplasm was done with
young MII oocytes (cryopreserved and wasted,
respectively) to an aged oocyte at an NSN-GV
stage of development (4, 12). In the OT technique,
about 5-15% of ooplasm was removed from the
recipient and replaced with donor ooplasm at 37°C
(4, 19). Notably, oocytes received ooplasm with
volume more than twice had no reprogramming
potential (4, 19). This technique was performed by
injecting the donor ooplasm into the recipient by a
standard ICSI micropipette (4). The OT techniques
were performed on the heated plate (37°C; THN-
60/16 and MS 100 Controller from Linkam Scientific
Instruments Ltd., London, UK) of an inverted
microscope at 200× or 400× magnification
(Diaphot, Nikon Corporation, Tokyo, Japan) by the
Hoffman Modulation Contrast System (Modulation
Optics Inc., Greenvale, NY, USA). The microscope
had two coarse positioning manipulators (3D
Motor-Driven Coarse control Manipulator MM-188,
Narishige) and two three-dimensional hydraulic
remote-control micromanipulators ( Joystick
Hydraulic Micromanipulator MO-188, Narishige,
Japan). The oocytes were rinsed and cultured in
the medium (G-MOPSTMPLUS, Vitrolife, Sweden)
with serum protein substitute 10% (SPS, IVF online
CT, USA) before ICSI.
2.4.4. Semen preparation
The fresh semen specimens were donated by
the normozoospermic male spouse of couples
registered in infertility clinic at the Avicenna
Research Institute, Tehran, Iran. None of the
subjects had any history of azoospermia,
leukocytospermia, chronic diseases (diabetes,
cancer, etc.), endocrine abnormalities, pelvic and
genital infections, Y-chromosome microdeletion,
and chromosomal aberrations. The assessment
of sperm motility and the count was done based
on the approvals of the World Health Organization
(20). Sperm parameters were normal when total
sperm motility (progressive + nonprogressive) ≥
40%, normal sperm morphology ≥ 4%, vitality ≥
58%, and sperm concentration was ≥ 15 million/ml
(20). Semen was permitted to liquefy at 20°C for 30
min, and the density gradient centrifugation (DGC)
method at 300g for 20 min with PureSperm®
(Nidacon, Gothenberg, Sweden) was used to
separate mature sperm.
2.4.5. Intracytoplasmic sperm injections
and embryo culture
All treated oocytes that reached the MII stage
were subjected to sperm injection (16). Only
one spermatozoon from the sperm droplet was
aspirated, tail-first, into the injection pipette. The
oocyte was fixed by the negative pressure of the
holding pipette in place of the polar body (PB) was
at 12 or 6 o’clock position. The injection pipette
was hard-pressed at 3 o’clock to the zona pellucida,
the oolemma, and the ooplasm below it while
a spermatozoon with about 1-2 picolitres of the
medium was inserted into the ooplasm.
The injection pipette was draw back calmly and
the injected oocyte was leaved from the holding
pipette. Then, the oocytes were washed in medium
(G-1TM, Vitrolife, Sweden), transferred into droplets
of medium (G-1TM, Vitrolife, Sweden), covered
by lightweight paraffin oil (OVOILTM-Culture oil,
Vitrolife, Sweden), and incubated (Heraeus, B5060
EK/O2, Van der Heyden, Brussels, Belgium; 37°C;
5% O2, 5% CO2, and 90% N2). About 18-20 hr after
the sperm injection, the oocytes were assessed
under the inverted microscope with a 200× or
400× magnification. The extrusion of second PB
and formation of pronuclei were assessed too.
Fertilization was normal when two clearly intact
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pronuclei were present. After confirmation of two
pronuclei fertilization (2PN), zygotes were cultured
in medium (G-1TM, Vitrolife, Sweden) covered by
paraffin oil (OVOILTM-Culture oil, Vitrolife, Sweden),
and incubated in an incubator (Heraeus, B5060
EK/O2, Van der Heyden, Brussels, Belgium; 37°C;
5% O2, 5% CO2, and 90% N2). Cleavage of two
pronuclear (2PN) oocytes was evaluated 24 hr
later. The assessment of embryo development was
carried out at 48 and 72 hr after the sperm injection
procedure (4). The embryo quality was counted
according to the homology of the blastomer’s size
and the number of anucleate fragments (4, 11).
2.4.6. Outcome measures
The primary outcome measures were the rates
of fusion (number of reconstructed NSN-GV aged
oocytes after manipulation), MI (number of NSN-
GV aged oocytes that reached MI stage), MII
(number of NSN-GV aged oocytes that reached
MII stage), ICSI (number of intact oocytes after
ICSI), PN observation (number of pronucleus
formation following ICSI), cleavage (number
of oocytes that cleaved following ICSI), and
percentage of embryos reaching 2-, 4-, and 8-cell
stages.
Oocytes were obtained from infertile
women undergoing ART treatment


















MII oocyte (≤ 
34 years old)
waOTsOT, GVTcaOT
ICSI and Evaluate the survival rate
Figure 1. Flow diagram showing the study design.
Figure 2. Illustration of aged NSN-GV oocytes treated with germinal vesicle transfer (GVT) method. Naked NSN-GV aged-oocytes
were obtained by removal of nucleus material “directly” with a small amount of surrounding cytoplasm (karyoplast). The GV-
karyoplast was inserted subzonally into an enucleated young oocyte. Membrane fusion between oocyte and karyoplast was
performed by electrofusion at room temperature. All treated oocytes that reached to MII stage were subjected to sperm injection.
ICSI, Intra cytoplasmic sperm injection; PN, pronuclear; NSN, not surrounded nucleolus; SN; surrounded nucleolus.
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Figure 3. Illustration of aged NSN-GV oocytes treated with three methods of ooplasmic transfer (OT) including synchronous
ooplasmic transfer (sOT), asynchronous ooplasmic transfer using cryopreserved MII oocyte (caOT), and asynchronous ooplasmic
transfer using waste MII oocyte (waOT). In sOT, the ooplasm of the young SN-GV replaced that of the aged NSN-GV, while in caOT
and waOT, the replacement of ooplasm was done with young MII oocytes to an aged oocyte at an NSN-GV stage of development.
All treated oocytes that received to MII stage were subjected to sperm injection. ICSI, Intra cytoplasmic sperm injection; PN,
pronuclear; NSN, not surrounded nucleolus; SN; surrounded nucleolus.
2.5. Ethical consideration
Informed consent was achieved from all
volunteers and the use of human oocytes
for this study was approved by the Medical
Ethics Committee of Avicenna Research Institute
(93/4390-93/01/01).
2.6. Statistical analysis
The statistical package for social sciences
(SPSS) software (version 22, Chicago, IL, USA)
was used for all analyses. Wilcoxon was used
for pairwise comparison between groups.
The Kaplan-Meier and Log rank were used
for evaluation of survival function in nine
developmental stages including fusion, MI,
MII, ICSI, PN, cleavage, 2-cell, 4-cell, and 8-
cell. The “cumulative proportion surviving at
end of interval”, “probability density”, “hazard
rate”, “number entering interval”, “proportion
terminating”, and “proportion surviving” rate
at all developmental stages were compared
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between groups. The “cumulative proportion
surviving at the end of interval” related to
the proportion of the cell surviving until the
end of the developmental stage. The “number
entering interval” showed the denominator cell
number for each time interval. The “proportion
terminating” represented the proportion of NSN-
GV oocytes that had died. The “proportion
surviving” represented the proportion of
NSN-GV oocytes that had survived during
the development. The “probability density”
and “hazard rates” for the life table and the
height of the survival curve were presented
too. In all statistical analyses, a P-value ≤
0.05 was set as significant. In all tables, four
groups of B, C, D, and E were compared
and group A has been removed due to
lack of changes and only was descripted
in the text. The sample size was based on
previous studies (21). However, since aged
women usually have a low ovarian reserve
and most of their retrieved oocytes are
used for their own treatment, we found it
very hard to obtain these samples for this
investigation.
3. Results
The descriptive and comparative statistics
of different methods utilized for improving the
fertilization and developmental potential of
human aged NSN-GV oocytes are shown in
Table I and the life table of different methods
utilized for improving the fertilization and
developmental potential of human aged NSN-
GV oocytes are shown in Table II. In group
A, none of the oocytes fused, so this group
has been removed from the analysis shown
in the tables. In group B, all oocytes fused
and 20 achieved the MI stage. Of these, 14
progressed to MII and 8 were fertilized. The
pronuclear formation was observed in six
resulting zygotes, all of which cleaved and
five, four, and three achieved a 2-cell, 4-cell
and 8-cell stage, respectively (Tables I, II). In
group C, all oocytes fused and achieved the
MI stage. Of these, eight progressed to MII
and showed signs of fertilization. Of the six
cleaved embryos, six, five, and five achieved
a 2-cell, 4-cell, and 8-cell stage, respectively
(Tables I, II). In group D, all oocytes fused,
five and three progressed to MI and MII,
respectively, but only one fertilized. This
zygote cleaved and reached a 4-cell stage
embryo (Tables I, II). In group E, six and two
oocytes progressed to MI and MII stages,
respectively. Of these, only one fertilized
but arrested at the zygote stage (Tables I,
II).
The cumulative survival rate, probability
density, hazard ratio, the number entering
an interval, proportion terminating, and the
surviving rate at all developmental stages
were compared between groups (Table II). A
human aged NSN-GV oocyte that achieved
the 8-cell stage development has been
illustrated in Figure 4. We found that group
C had a higher survival rate than groups
B (p < 0.05), D (p < 0.005), and E (p <
0.001) (Table I). Cumulative survival rate at
the 8-cell stage was respectively higher in
group C (0.42) and B (0.12) than the other
groups (Table II). In other words, this gives
42% and 12% probability of surviving up to
the 8-cell stage following caOT and sOT,
respectively, in groups C and B. The Proportion
Surviving represents the proportion of NSN-GV
oocytes that survived during the development.
Therefore, for groups C and B, the probability
of surviving during 8-cell development was
1.00 (approximately 100%) (Table II). The
developmental potential of human aged NSN-GV
oocytes in groups B, C, D, and E are shown in
Figure 5.
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Table I. Descriptive and comparative statistics of different methods utilized for improving the fertilization and developmental
potential of human aged NSN-GV oocytes
Parameters \
Variations (%)
Fusion MI MII ICSI PN Cleavage 2-cell 4-cell 8-cell Survival
rate
P-value
B vs C 0.04*
B vs D 0.04*Group B (n = 26) 100 76.92 53.85 30.77 23.08 23.08 19.23 15.38 11.54 30.76
cde
B vs E 0.03*
C vs B 0.04*
C vs D 0.002*Group C (n = 12) 100 100 66.70 66.70 66.70 50 50 41.66 41.66 61.11
bde
C vs E 0.001*
D vs B 0.04*
D vs C 0.002*Group D (n = 12) 100 41.66 25 8.30 8.30 8.30 8.30 8.30 0 13.88
bc
D vs E 0.90
E vs B 0.03*
E vs C 0.001*Group E (n = 12) - 50 16.70 8.30 0 0 0 0 0 8.33
bc
E vs D 0.90
Wilcoxon was used for pairwise comparison between groups. Here, four groups of B, C, D and E were compared. Group A has
been removed due to lack of changes and only has only been descripted in the text. The data were reported as a percentage. In
this table, nine parameters related to the fertilization, and developmental potential of oocytes including fusion, MI, MII, ICSI, PN,
cleavage, 2-cell, 4-cell, and 8-cell were compared between groups. For analyzing and comparing the data, the Kaplan-Meire
and Log rank were used for the evaluation of survival function in the nine developmental stages. The P-value of comparing
“survival rates” between groups have been shown in the last column of this table. *P ≤ 0.05; significant, **P ≤ 0.001; highly
significant. Group A, germinal vesicle transfer (GVT); Group B, synchronous ooplasmic transfer (sOT); Group C, asynchronous
ooplasmic transfer using cryopreserved MII oocyte (caOT); Group D, asynchronous ooplasmic transfer using waste MII oocyte
(waOT); Group E, control group. ICSI, Intra cytoplasmic sperm injection; PN, pronuclear
Table II. Life table of different methods utilized for improving the fertilization and developmental potential of human aged NSN-GV
oocytes
Group Fusion MI MII ICSI PN Cleavage 2-cell 4-cell 8-cell
Cumulative proportion surviving at end of interval
B 0.77 0.54 0.31 0.23 0.23 0.19 0.15 0.12 0.12
C 1.00 0.67 0.67 0.67 0.50 0.50 0.42 0.42 0.42
D 0.42 0.25 0.08 0.08 0.08 0.08 0.08 0.00 -
E 0.50 0.17 0.08 0.00 - - - - -
Probability density
B 0.23 0.23 0.23 0.08 0.00 0.04 0.04 0.04 0.00
C 0.00 0.33 0.00 0.00 0.17 0.00 0.08 0.00 0.00
D 0.58 0.17 0.17 0.00 0.00 0.00 0.00 0.08
E 0.50 0.33 0.08 0.08 - - - - -
Hazard rate
B 0.26 0.35 0.55 0.29 0.00 0.18 0.22 0.29 0.00
C 0.00 0.40 0.00 0.00 0.29 0.00 0.18 0.00 0.00
D 0.82 0.50 1.00 0.00 0.00 0.00 0.00 2.00 -
E 0.67 1.00 0.67 2.00 - - - - -
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Table II. Continued
Group Fusion MI MII ICSI PN Cleavage 2-cell 4-cell 8-cell
Number entering interval
B 26 20 14 8 6 6 5 4 3
C 12 12 8 8 8 6 6 5 5
D 12 5 3 1 1 1 1 1 0
E 12 6 2 1 0 0 0 0 0
Proportion terminating
B 0.23 0.30 0.43 0.25 0.00 0.17 0.20 0.25 0.00
C 0.00 0.33 0.00 0.00 0.25 0.00 0.17 0.00 0.00
D 0.58 0.40 0.67 0.00 0.00 0.00 0.00 1.00 -
E 0.50 0.67 0.50 1.00 - - - - -
Proportion surviving
B 0.77 0.70 0.57 0.75 1.00 0.83 0.80 0.75 1.00
C 1.00 0.67 1.00 1.00 0.75 1.00 0.83 1.00 1.00
D 0.42 0.60 0.33 1.00 1.00 1.00 1.00 0.00 -
E 0.50 0.33 0.50 0.00 - - - - -
The Kaplan-Meire and Log-rank were used for the evaluation of survival function in nine developmental stages including Fusion,
MI, MII, ICSI, PN, Cleavage, 2-cell, 4-cell, and 8-cell. Here, four groups of B, C, D, and E were compared. Group A has been
removed due to the lack of changes and has only been described in the text. Group A, germinal vesicle transfer (GVT); Group
B, synchronous ooplasmic transfer (sOT); Group C, asynchronous ooplasmic transfer using cryopreserved MII oocyte (caOT);
Group D, asynchronous ooplasmic transfer using waste MII oocyte (waOT); Group E, control group. ICSI, Intra cytoplasmic sperm
injection; PN, pronuclear; NSN, not surrounded nucleolus; SN, surrounded nucleolus. Cumulative proportion surviving at the
end of interval: the proportion of the cell surviving until the end of the developmental stage; Proportion surviving: the proportion
of NSN-GV oocytes which survived during development; Proportion terminating: the proportion of NSN-GV oocytes which died;
Number entering interval: the denominator cell number for each time interval
Figure 4. Developmental potential of human aged NSN-GV oocytes in group B, C, D, and E. Generalized Wilcoxon was used for
comparisons (Chi-Square:16.53, df: 3, P-value: 0.001). Group A, germinal vesicle transfer (GVT); group B; synchronous ooplasmic
transfer (sOT); group C, asynchronous ooplasmic transfer using cryopreserved MII oocyte (caOT); group D, asynchronous
ooplasmic transfer using waste MII oocyte (waOT); and group E, control. NSN, not surrounded nucleolus; SN, surrounded
nucleolus.
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Figure 5. A human aged NSN-GV oocyte that achieved the 8-cell stage development observed by invert microscopy (400×
magnification). In our study, cleavage zygotes were observed with all but GVT methods. However, asynchronous ooplasmic
transfer using cryopreserved MII oocytes (caOT) resulted in more zygotes achieving the 2-cell, 4-cell, and 8-cell stages than the
other methods.
4. Discussion
To the best of our knowledge, this is the first
study to compare the effectiveness of methods
aiming at improving the reproductive potential
of human aged NSN-GV oocytes. We evaluated
four three-parent techniques and found that
the caOT technique seems to be advantageous
over sOT, waOT, and GVT concerning the
developmental capacity of human-aged NSN-GV
oocytes. Notwithstanding these promising results,
our study has several limitations as the number
of NSN-GV oocytes utilized was small due to the
inherent difficulties to obtain human oocytes for
research.
GVT has been the most studied method to
improve oocyte quality. It involves the removal
of nuclear chromosomal content from aged
oocytes and transplantation into enucleated
healthy oocytes (12, 16, 22). In this study,
we were not successful in achieving embryo
development in any aged NSN-GV RO, owing to
the problems in gathering the nuclear structure
even after using medium supplemented with
IBMX. Studies in other mammal species reported
variable success with GVT (16). The discrepancy
between our results and those of others might
be attributable to the use of different oocyte
source. Previous studies lack information
concerning the type of GV oocyte utilized -
SN or NSN. We speculate that GVT was too
invasive for use with NSN-GV oocytes. It has
been shown that from mitochondrial dysfunction
of aging, oocytes might cause peroxidative
damage to nuclear DNA or cell membranes,
ultimately resulting in cellular function decay
(4, 12). Furthermore, studies reported that some
oocytes that had matured in vitro underwent
apoptosis (4, 12). It seems that these mechanisms
can explain the failure of GVT in aged NSN-GV
oocyte.
By contrast, our results suggest that the three
other methods might be potentially useful to
improve oocyte quality of aged NSH-GV oocytes.
As compared with group A (GVT), the rates of
oocyte fusion were 100% in groups B (sOT), C
(caOT), and D (waOT).
After oocyte fusion, GV oocytes have to
progress to the next developmental stages. The
extrusion of the first and second polar bodies
is used as markers of nuclear maturation and
meiosis completion (23, 24). In this study, the
mean percentage of oocytes achieving the MI
stage was 0% in GVT compared with 76.9% in
sOT, 100.0% in caOT, 41.7% in wOT, and 50.0% in
the control group (Group E). The ratio of oocytes
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reaching the MI stage was significantly higher in
the sOT and caOT than in the waOT and control
oocytes. Likewise, the percentage of oocytes
arrived at MII stage was significantly higher in
sOT, caOT, and wOT than in the GVT and control
groups.
The extrusion of the second PB and formation
of pronuclei occur approximately 18-20 hr and
20-24 hr after sperm injections, respectively
(12). Our results indicate that the likelihoods of
NSN aged-GV-treated oocytes to be fertilized are
very low (< 10%) with GVT or wOT methods.
By contrast, fertilization rates were highest with
caOT (∼66%) followed by sOT (∼30%), and
both methods had higher 2PN fertilization rates
than controls (∼8%). Notably, in this study, we
showed that the 2PN fertilization rate observed
with the caOT method was similar than that
of achieved after sperm injection of mature
oocytes in ART programs. In our study, cleavage
zygotes were observed with all but GVT methods.
However, asynchronous ooplasmic transfer using
cryopreservedMII oocytes [caOT] resulted inmore
zygotes achieving the 2-cell, 4-cell, and 8-cell
stages than the other methods.
Our results indicate that cytoplasmic transfer
into human aged NSN-GV oocytes might improve
preimplantation development. Considering all
maturation and development stages, caOT
was the most efficacious method to improve
the fertilization and developmental capacity of
aged NSN-GV. This approach might increase
the reproductive success of aged women with
infertility that usually has a limited and poor-quality
oocyte cohort available for fertilization.
Although some studies assessed the effects
of NT or OT techniques on oocyte maturation
(4, 12, 16), to our knowledge, no study has
evaluated the effects of these techniques on the
quality of aged NSN-GV oocytes. Studies showed
that NT or OT are useful to improve ooplasmic
maturation in mammalian oocytes, but our result
showed that the caOT method was beneficial
over sOT, waOT, and GVT in supplementing the
developmental capacity of human aged NSN-GV
oocytes. It is reported that children born using
the OT may exhibit mitochondrial heteroplasmy
(12, 25, 26). However, the levels of heteroplasmy
were not assessed in this study and this important
aspect should be investigated in the 8-cell stage
in future studies. The recipient oocyte also
has other molecules and organelles that may
induce genomics, transcriptomics, proteomics,
metabolomics, and epigenomics alterations (12,
27). Along the same lines, the assessment of
blastocyst development and embryo genetic and
epigenetic status of resulting embryos were
not carried out and should be investigated
further.
The techniques for improving oocyte quality
of mammalian oocytes are evolving. However,
there are several gaps in the knowledge that
need to be investigated in future research.
Besides embryo genetic competence, it is
important to investigate the well-being of the
offspring generated. There is a risk that genetic
and epigenetics modifications are incurred
during the application of these methods. RNAs,
proteins, mitochondria, associated structures,
and energetics substrates are transferred from
donor to recipient oocytes (12, 28), and children
born using these parent techniques were shown
to exhibited mitochondrial heteroplasmy (12).
The complex interactions between nuclear DNA
and mtDNA as well as with other molecules
might cause epigenetic alterations of the
nuclear genome which requires close monitoring
(28).
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5. Conclusion
The asynchronous ooplasmic transfer using
cryopreserved MII oocytes technique (caOT)
seems to be advantageous over sOT, waOT, and
GVT in the developmental capacity of human-
aged NSN-GV oocytes. caOT holds promise
concerning its possible role in augmenting the
developmental capacity of human aged NSN-
GV in terms of fertilization and cleavage, thus
warranting further investigation.
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